Literature DB >> 7305895

Random, presumably hydrolytic, and lysosomal glycogenolysis in the livers of rats treated with phlorizin and of newborn rats.

P Devos, H G Hers.   

Abstract

1. The glycogen formed in the livers of adult rats was labelled by injection of [1-14C] galactose soon after initiation of re-feeding after starvation. The rats were anaesthetized 4h later and glycogenolysis was induced by giving them a mixture of glucagon and insulin. In confirmation of previous work [Devos & Hers (1979) Eur J. Biochem. 99, 161-167],, there was a delay in degradation of the labelled glycogen by comparison with total glycogen. This pattern is considered as characteristic of an ordered glycogenolysis. Treatment of rats with phlorizin abolished the difference between the fate of labelled and total glycogen, causing, therefore, a random glycogenolysis. 2. Foetal liver glycogen was made radioactive by injecting [14C] glucose into the mother at the 19.5 day of gestation, i.e. at the time when this glycogen starts to be synthesized. During the postnatal degradation of this glycogen, radioactive and total glycogen were degraded at approximately the same rate, indicating that glycogenolysis occurred at random. In contrast, when puromycin was injected into the newborn rats, there was a delay in he degradation of the labelled glycogen as compared with that of total glycogen, as currently observed in the normal adult liver. 3. These data are discussed in relation with the fact that glycogen-filled vacuoles are currently seen in the livers of adult rats treated with phlorizin, and also in the neonatal livers, and that puromycin is known to cause the disappearance of these autophagic pictures in the liver of newborn rats. It is suggested that random glycogenolysis occurs through hydrolysis by the lysosomal acid alpha-glucosidase, in the course of autophagy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7305895      PMCID: PMC1162320          DOI: 10.1042/bj1920177

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Tissue fractionation studies. 16. Intracellular distribution and properties of alpha-glucosidases in rat liver.

Authors:  N LEJEUNE; D THINES-SEMPOUX; H G HERS
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

2.  [Morphology of glycogen. Electron microscopic study of the negative stains of particulate glycogen].

Authors:  P DROCHMANS
Journal:  J Ultrastruct Res       Date:  1962-04

3.  A molecular order in the synthesis and degradation of glycogen in the liver.

Authors:  P Devos; H G Hers
Journal:  Eur J Biochem       Date:  1979-08-15

4.  Fine structural aspects of the mobilization of hepatic glycogen. I. Acceleration of glycogen breakdown.

Authors:  O B Kotoulas; M J Phillips
Journal:  Am J Pathol       Date:  1971-04       Impact factor: 4.307

5.  Studies of lysosomal alpha-glucosidase. I. Purification and properties of the rat liver enzyme.

Authors:  P L Jeffrey; D H Brown; B I Brown
Journal:  Biochemistry       Date:  1970-03-17       Impact factor: 3.162

6.  The fine structure of the normal, neonatal mouse liver.

Authors:  A M Jézéquel; K Arakawa; J W Steiner
Journal:  Lab Invest       Date:  1965-11       Impact factor: 5.662

7.  Phlorizin induced autophagocytosis during hepatocytic glycogenolysis.

Authors:  F F Becker; C C Cornwall
Journal:  Exp Mol Pathol       Date:  1971-02       Impact factor: 3.362

8.  Glycogen depletion in the newborn rat liver: an electron microscopic and electron histochemical study.

Authors:  M J Phillips; N J Unakar; G Doornewaard; J W Steiner
Journal:  J Ultrastruct Res       Date:  1967-04

9.  Effect of puromycin on hepatic glycogen phosphorylase activity.

Authors:  J F Hofert; R K Boutwell
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

10.  Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes.

Authors:  R L Deter; C De Duve
Journal:  J Cell Biol       Date:  1967-05       Impact factor: 10.539

View more
  12 in total

Review 1.  Autophagy in the liver: functions in health and disease.

Authors:  Takashi Ueno; Masaaki Komatsu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

2.  Loss of Autophagy Causes Increased Apoptosis of Tibial Plateau Chondrocytes in Guinea Pigs with Spontaneous Osteoarthritis.

Authors:  Xiao-Jian Wang; Wei Tian; Wei-Wei Xu; Xiao Lu; Yu-Ming Zhang; Li-Jun Li; Feng Chang
Journal:  Cartilage       Date:  2021-09-07       Impact factor: 3.117

3.  Glycogen metabolism in the liver of the neonatal gsd/gsd and control (GSD/GSD) rat.

Authors:  D G Clark; S D Neville; M Brinkman; O H Filsell
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

4.  Glycogenolysis in liver of phosphorylase kinase-deficient rats during liver perfusion and ischaemia.

Authors:  G Lutaya; R J Sharma; J R Griffiths
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

5.  Dysfunctional glycogen storage in a mouse model of alpha1-antitrypsin deficiency.

Authors:  Ralf H Hubner; Philip L Leopold; Maija Kiuru; Bishnu P De; Anja Krause; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

6.  Disturbance of lysosomal glycogen metabolism by liposomal anti-alpha-glucosidase and some anti-inflammatory drugs.

Authors:  R Geddes; D E Otter; G K Scott; J A Taylor
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

7.  The catalytic activity of phosphorylase b in the liver. With a note on the assay in the glycogenolytic direction.

Authors:  W Stalmans; G Gevers
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

8.  Quantitative analysis of intermediary metabolism in hepatocytes incubated in the presence and absence of glucagon with a substrate mixture containing glucose, ribose, fructose, alanine and acetate.

Authors:  M Rabkin; J J Blum
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

9.  Brain glycogen-new perspectives on its metabolic function and regulation at the subcellular level.

Authors:  Linea F Obel; Margit S Müller; Anne B Walls; Helle M Sickmann; Lasse K Bak; Helle S Waagepetersen; Arne Schousboe
Journal:  Front Neuroenergetics       Date:  2012-03-02

10.  SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Konstantina Fylaktakidou; Efthimios Sivridis; Christos E Zois; Dimitra Kalamida; Achilleas Mitrakas; Stamatia Pouliliou; Ilias V Karagounis; Konstantinos Simopoulos; David J P Ferguson; Adrian L Harris
Journal:  Invest New Drugs       Date:  2018-01-31       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.